ABC News, 29.6.18 Up to 300 people a day are expected to use Victoria’s first medically supervised drug injecting room when it opens in the coming days. The Victorian Government committed to a two-year trial at the North Richmond Community Health Centre, after three separate coroners called for a supervised space. Mental Health Minister Martin Foley said it would save lives. Read more of...
Hepatitis SA, January 2018 Hepatitis SA invites you to The 2018 HepLINK Forum: Engaging Marginalised Populations in Hepatitis C Treatment Thjis will be held on Thursday, 1 March, 11am–2pm (lunch provided), at the Education Development Centre (EDC), 4 Milner St, Hindmarsh. Keynote speaker: Dr Phillip Read, Director, Kirketon Road Centre Dr Phillip Read is a sexual health physician and the Director...
SA Health, October 2017 From 1 January 2018, Mission Australia Hindmarsh Centre after-hours Clean Needle Program (CNP) service component (Monday to Friday 5pm to 8pm) will discontinue. However, the daytime CNP service at the Hindmarsh Centre, provided by Hepatitis SA staff will continue Monday to Friday 1.30pm to 5.00pm, with syringe vending machine services available 24 hours per day 7 days per...
6th International Symposium on Hepatitis Care in Substance Users, 6th Sept 2017 An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them. “The number of people around the world dying from hepatitis C is increasing. We have the tools to...
The Conversation, July 31, 2017 4.05pm AEST The World Health Organisation recently set ambitious goals for the “elimination of hepatitis C as a major public health threat”. These included having 80% of people treated and an 80% reduction in the spread of the virus by 2030. Given there are around 70 million people infected with hep C worldwide, only 20% diagnosed, and no effective vaccine, the...
The Kirby Institute, UNSW, May 2017 The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibodies and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia. Conducted annually over a one-two week period in October, all clients attending participating...